Mette Bjerre Selected Research

Troponin I

11/2014	Low adiponectin levels and increased risk of type 2 diabetes in patients with myocardial infarction.
2/2012	Usefulness of adiponectin as a predictor of all cause mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
1/2012	Osteoprotegerin predicts long-term outcome in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mette Bjerre Research Topics

Disease

16	Inflammation (Inflammations) 12/2023 - 07/2010
14	Type 2 Diabetes Mellitus (MODY) 09/2023 - 06/2010
12	ST Elevation Myocardial Infarction 03/2017 - 01/2009
11	Myocardial Infarction 03/2023 - 01/2009
11	Cardiovascular Diseases (Cardiovascular Disease) 03/2023 - 07/2011
9	Insulin Resistance 01/2023 - 10/2010
8	Heart Failure 01/2018 - 08/2010
7	Coronary Artery Disease (Coronary Atherosclerosis) 10/2021 - 07/2011
6	Out-of-Hospital Cardiac Arrest 12/2023 - 11/2014
6	Neoplasms (Cancer) 07/2023 - 02/2011
6	Infections 01/2023 - 06/2010
6	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 02/2021 - 01/2012
5	Hypertension (High Blood Pressure) 01/2017 - 02/2012
5	Atherosclerosis 12/2013 - 02/2012
4	Ischemia 01/2023 - 07/2011
4	Acute Coronary Syndrome 03/2015 - 08/2010
3	Coma (Comas) 12/2023 - 04/2016
3	Stroke (Strokes) 03/2023 - 04/2016
3	Necrosis 01/2020 - 07/2009
3	Obesity 12/2019 - 06/2010
3	Diabetic Nephropathies (Diabetic Nephropathy) 08/2015 - 01/2012
3	Hypercholesterolemia 11/2014 - 02/2012
3	Ischemic Stroke 04/2013 - 02/2012
3	Reperfusion Injury 11/2012 - 07/2010
3	Myocardial Ischemia (Ischemic Heart Diseases) 02/2012 - 04/2010
2	Brain Injuries (Brain Injury) 12/2023 - 01/2023
2	Hyperinsulinism (Hyperinsulinemia) 01/2023 - 04/2013
2	Common Variable Immunodeficiency 09/2022 - 10/2019
2	Coronary Disease (Coronary Heart Disease) 10/2021 - 01/2020
2	Lymphoma (Lymphomas) 07/2021 - 12/2020
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2018 - 01/2015
2	Sleep Apnea Syndromes (Sleep Apnea) 04/2018 - 03/2013
2	Body Weight (Weight, Body) 04/2018 - 12/2011
2	Hemolysis 01/2018 - 02/2010
2	Chronic Kidney Failure (Chronic Renal Failure) 09/2014 - 07/2013
2	Heart Diseases (Heart Disease) 12/2013 - 01/2013
2	Vascular Calcification 09/2013 - 07/2013
2	Diabetes Mellitus 11/2012 - 04/2012
1	Post-Cardiac Arrest Syndrome 12/2023
1	Metabolic Diseases (Metabolic Disease) 09/2023
1	Cushing Syndrome 07/2023
1	Thyroid Neoplasms (Thyroid Cancer) 07/2023
1	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 01/2023
1	Hypoxia (Hypoxemia) 01/2023
1	Glucose Intolerance 01/2022
1	Chronic Disease (Chronic Diseases) 10/2021
1	Disease Progression 10/2021
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 07/2021
1	T-Cell Lymphoma (Lymphoma, T Cell) 07/2021
1	Leukemia 07/2021

Drug/Important Bio-Agent (IBA)

15	OsteoprotegerinIBA 01/2020 - 08/2010
14	Biomarkers (Surrogate Marker)IBA 01/2023 - 04/2010
11	C-Reactive ProteinIBA 01/2023 - 06/2010
10	AdiponectinIBA 12/2019 - 07/2011
6	Interleukin-6 (Interleukin 6)IBA 12/2023 - 07/2009
5	Proteins (Proteins, Gene)FDA Link 09/2023 - 09/2014
5	CytokinesIBA 01/2023 - 07/2009
5	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 04/2012
5	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 01/2021 - 02/2011
5	Insulin-Like Growth Factor I (IGF-1)IBA 08/2020 - 12/2011
5	Complement System Proteins (Complement)IBA 01/2018 - 01/2009
4	fibroblast growth factor 21IBA 09/2023 - 12/2019
4	Pregnancy-Associated Plasma Protein-A (PAPP-A)IBA 03/2023 - 03/2015
4	Insulin (Novolin)FDA Link 02/2021 - 07/2010
4	Insulin-Like PeptidesIBA 05/2017 - 04/2013
3	Insulin-Like Growth Factor Binding Protein 4IBA 03/2017 - 03/2015
3	Advanced Glycation End ProductsIBA 03/2015 - 01/2015
3	Troponin IIBA 11/2014 - 01/2012
3	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 11/2012 - 06/2010
2	Phosphopyruvate Hydratase (Enolase)IBA 12/2023 - 01/2023
2	LipopolysaccharidesIBA 01/2023 - 02/2021
2	C-PeptideIBA 01/2023 - 03/2015
2	LigandsIBA 07/2021 - 01/2015
2	Programmed Cell Death 1 ReceptorIBA 07/2021 - 12/2020
2	EnzymesIBA 07/2021 - 01/2016
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2020 - 06/2014
2	LectinsIBA 10/2019 - 02/2011
2	Interleukin-10 (Interleukin 10)IBA 01/2017 - 07/2009
2	OsteopontinIBA 09/2014 - 12/2013
2	Glycoproteins (Glycoprotein)IBA 12/2013 - 09/2013
2	omega-Chloroacetophenone (Mace)IBA 04/2013 - 11/2012
2	Leukocyte L1 Antigen Complex (Calgranulin)IBA 10/2012 - 04/2010
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 07/2011 - 08/2010
1	Methylprednisolone FDA LinkGeneric 12/2023
1	Metformin (Glucophage)FDA LinkGeneric 09/2023
1	Adrenocorticotropic Hormone (ACTH)FDA Link 07/2023
1	Corticotropin-Releasing HormoneIBA 07/2023
1	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 07/2023
1	pro-brain natriuretic peptide (1-76)IBA 01/2023
1	Trinitrotoluene (TNT)IBA 01/2023
1	tocilizumab (atlizumab)FDA Link 01/2023
1	Neuroprotective AgentsIBA 01/2023
1	ImmunosorbentsIBA 07/2021

Therapy/Procedure

12	Percutaneous Coronary Intervention 03/2017 - 01/2009
4	Induced Hypothermia 01/2023 - 11/2014
4	Transplantation 09/2014 - 02/2011
2	Surgical Amputation (Amputations) 03/2023 - 07/2013
2	Aftercare (After-Treatment) 12/2020 - 01/2020
1	Intravenous Injections 12/2023
1	Immunotherapy 07/2021